LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Granules India Limited
03 1Jai Radhe Sales
04 1Laboratorium Ofichem B.V
05 1Aarti Pharmalabs
06 1HRV Global Life Sciences
07 1Supriya Lifescience
08 1Alembic Pharmaceuticals Limited
09 1Alkem Laboratories
10 1Aspire Lifesciences Pvt Ltd
11 1Aurobindo Pharma Limited
12 1Beijing Cooperate Pharmaceutical Co. Ltd
13 1Cadila Pharmaceuticals
14 1Chemeca Drugs
15 2Chemi SpA
16 1Chemino Pharma
17 1Cilag AG
18 1Derivados Quimicos SAU
19 1Dipharma
20 1Divis Laboratories
21 1Emnar Pharma
22 1Erregierre SpA
23 1Freemen Nutra
24 2Glenmark Life Sciences
25 1Glenmark Pharmaceuticals
26 1Globe Quimica Ltda
27 1Guangzhou Tosun Pharmaceutical
28 1HANZHONG HANJIANG VENTUREPHARM PHARMACEUTICAL LTD
29 1Hermes Chemical
30 2Hetero Drugs
31 2Hikal
32 1IIQUIAP
33 1Ipca Laboratories
34 1Jubilant Generics
35 1Jubilant Pharmova
36 1Lupin Ltd
37 1NORDIC SYNTHESIS AB
38 1Nishchem International Pvt. Ltd
39 1Olon S.p.A
40 1Om Pharmaceutical Industries
41 1Sai Tech Pharmaceuticals Pvt Ltd
42 1Seven Star Pharmaceutical
43 1Sifavitor srl
44 1Sms Lifesciences
45 1Solmag
46 1Sun Pharmaceutical Industries Limited
47 1UQUIFA
48 1Virchow Group
49 1ZHEJIANG LANGHUA PHARMACEUTICAL CO., LTD.
50 1Zhejiang Apeloa Jiayuan Pharmaceutical
51 1Zhejiang Shaxing Pharm. & Chem
52 2Zhejiang Supor Pharmaceuticals Co., LTD
53 2Zydus Lifesciences
01 1Brazil
02 9China
03 34India
04 7Italy
05 1Mexico
06 1Netherlands
07 2Spain
08 1Sweden
09 1Switzerland
10 1Taiwan
11 1U.S.A
01 26Active
02 12Inactive
03 21Blank
01 59Blank
01 59Blank
01 1WC-0057A3
02 1WC-0057n
03 1WC-0066
04 1WC-0074
05 1WC-0083
06 1WC-0092
07 1WC-0094
08 1WC-0099
09 1WC-0159
10 1WC-0218
11 49Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-05-27
Pay. Date : 2021-04-15
DMF Number : 35694
Submission : 2021-03-29
Status : Active
Type : II
NDC Package Code : 62207-976
Start Marketing Date : 2021-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ROW |
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
NDC Package Code : 62675-1456
Start Marketing Date : 2019-12-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-19
Pay. Date : 2013-06-25
DMF Number : 27204
Submission : 2013-06-17
Status : Active
Type : II
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm :
NDC Package Code : 15308-0412
Start Marketing Date : 2010-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33538
Submission : 2019-01-25
Status : Active
Type : II
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34285
Submission : 2019-10-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20085
Submission : 2006-12-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11196
Submission : 1994-11-14
Status : Inactive
Type : II
We have 53 companies offering AM20060780
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?